🦊/Investors

Ballast Point VenturesFull Portfolio

21 tracked investments · listed companies and verified rows first

BioTissuebiotissue.cominSeries A · Aug 2013 · $10M✓ verified

BioTissue develops regenerative medicine products derived from human birth tissue to treat wounds and chronic pain.

BiotechHealthtechMedical DevicesMiami, US

Scheffer C.G. Tseng(Chief Scientific Officer)

Co-investorsEssex Woodlands Healthcare Partners

Keen Decision Systemskeends.comin𝕏Series B · Jun 2022 · $11M

Keen is a SaaS platform that helps marketing leaders at Fortune 500 and other companies use data and decision-science algorithms to guide marketing spend decisions and measure their impact on revenue, profitability, and long-term brand value.

AI & Machine LearningMarketing TechSaaSDurham, US

Greg Dolan(CEO and Co-founder)inMike Althoff(Chief Operating Officer)inBradley(Chief Revenue Officer)John Gu(Director)inJohn Busbice(Chief Decision Science Officer and Founder)Ellen Grantham(Executive Officer)

Board seatSean Barkman· per SEC Form D

Spotiospotio.cominSeries A · Dec 2019 · $5M

SPOTIO is a field sales execution platform with AI tools for reps working in the field, offering territory management, voice and photo data capture, next-best-action recommendations, and follow-up drafting.

AI & Machine LearningSaaSSales TechDallas, US

Trey Gibson(Executive Officer, Director)in

Board seatSean Barkman· per SEC Form D

Co-investorsCreativeCo

Viirtue, Incviirtue.comin𝕏Series A · Mar 2023 · $11M

Viirtue is a wholesale VoIP platform for MSPs, telecoms, and service providers, built around resellers and covering quoting, provisioning, billing, usage rating, tax automation, and compliance.

AI & Machine LearningCloud ComputingEnterprise SoftwareSaaSSt. Petersburg, US

DANIEL ROSENRAUCH(Executive Officer, Director, Promoter)inROBERT FINCH(Executive Officer, Director, Promoter)

Board seatSean Barkman· per SEC Form D

Y-Primeyprime.comin𝕏Oct 2017

YPrime provides a clinical trial technology platform with patient engagement features (eConsent and eCOA) designed to accelerate trial timelines, improve data quality, and enhance participant experience for pharmaceutical companies, biotechs, and contract research organizations.

BiotechDigital HealthEnterprise SoftwareHealthtechMedical DevicesSaaSMalvern, US

Jaime Cook(Executive Officer, Director)inShawn Blackburn(Executive Officer, Director)in

BoardMatthew Rice(Director)inElizabeth Tallett(Director)Richard Gastineau(Director)Paul Blake(Director)

Board seatSean Barkman· per SEC Form D

Co-investorsFlexpoint FordGray Ventures

AVOXIavoxi.comin𝕏Dec 2018 · $10M

AVOXI provides cloud-based voice and communications services with an international footprint.

Cloud ComputingEnterprise SoftwareSaaSAtlanta, US

Greg Buckalew(Senior Vice President of Operations)inBarbara DondiegoinDavid Wise(Executive Officer, Director)Wain Kellum(Director)Weston Edmunds(Executive Officer, Director)in

Co-investorsGray VenturesSavano Capital Partners

Carevisocareviso.comin𝕏Series B · Sep 2022 · $17M

Careviso automates prior authorization and administrative workflows in healthcare using its seeQer platform, helping patients understand treatment options and financial implications while reducing provider burden.

Digital HealthEnterprise SoftwareHealthtechSaaSFalls Church, US

Andrew Mignatti(Founder)inPerry Dimas(Founder)in

Co-investorsLytical VenturesMercury FundXB Ventures

Mailprotectormailprotector.comSeries A · Mar 2020 · $5M

Mailprotector provides email security services for managed service providers (MSPs), including zero trust threat filtering, email encryption, spam/malware filtering across Microsoft, Google, and on-premises environments, and email security analysis.

CybersecurityEnterprise SoftwareSaaS

MedsenderinSeries A · Feb 2025 · $5M

HealthtechNew York, US

Salman Haque(Executive Officer, Director)Zain Qayyum(Executive Officer, Director)

BoardJainal Bhuiyan(Director)Matthew Rice(Director)

Co-investorsBallast

PaceMate®pacemate.comSeries A · Mar 2021 · $8M

PaceMate operates a cloud-based platform for remote cardiac implantable electronic device (CIED) monitoring, aggregating data from cardiac devices and EHRs to manage patient triage, workflows, clinical research, and billing.

Digital HealthHealthtechMedical DevicesClearwater, US

Tripp Higgins(Founder)

Co-investorsLead Edge Capital

PowerChordpowerchord.cominJan 2016

PowerChord provides a unified marketing data dashboard that consolidates information from multiple marketing channels to help businesses track campaign performance and revenue attribution.

AdTechAI & Machine LearningEnterprise SoftwareMarketing TechSaaSSt. Petersburg, US

Lanny Tucker(Executive Officer, Director)inPatrick Shunk(Executive Officer, Director)Mark Regan(Executive Officer)inPeter Quintas(Executive Officer)in

BoardRobert Faber(Director)in

SkuVaultskuvault.comin𝕏Series A · Nov 2018 · $8Macquired by Linnworks

Linnworks provides a platform that connects inventory, orders, warehouses, listings, and shipping carriers across 100+ marketplaces and sales channels, keeping stock levels synced and automating order routing and fulfillment.

E-commerceRetail TechSaaSLouisville, US

Thomas Andrew Eastes(Chief Executive Officer)Svyatoslav Ivanyuk(Chief Technology Officer)

Co-investorsGray VenturesPoplar Ventures

Symphonic DistributioninJan 2022 · $37M

Tampa, US

Jorge Brea(Executive Officer, Director)inRobert Faber(Director)inMaria A. Santoni-Rodriguez(Director)

The Zebrathezebra.comSeries A · Jan 2016 · $17M

Co-investorsAccelCanvas VenturesEQUIAMFinTech VenturesFloodgateIA Capital Group+3 more

VAZATAvazata.comNov 2009 · $8M

VAZATA is a data center and managed colocation provider operating multiple facilities across North Texas, offering colocation, managed cloud hosting, and cloud computing services.

Cloud ComputingEnterprise SoftwareGovTech

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Abacode, Inc.KeyView LabsTakt, Inc.Iconixx SoftwareIntelligent Retinal Imaging SystemsWork Shield

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.